|
Volumn 90, Issue 3, 2001, Pages 343-352
|
Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTICS;
PHYSIOLOGY;
POLYMERASE CHAIN REACTION;
GASTROINTESTINAL TRACT;
HUMAN INTESTINE;
LACTOBACILLUS GASSERI;
MICROFLORAE;
ORAL ADMINISTRATION;
P-CRESOL;
PARENT STRAIN;
PCR METHOD;
PROBIOTICS;
RANDOMLY AMPLIFIED POLYMORPHIC DNA;
METABOLISM;
LG 2055SR;
PROBIOTIC AGENT;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL METABOLISM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FECES ANALYSIS;
FEMALE;
GENE AMPLIFICATION;
HUMAN;
INTESTINE FLORA;
LACTOBACILLUS;
LACTOBACILLUS GASSERI;
MALE;
NORMAL HUMAN;
POLYMERASE CHAIN REACTION;
STAPHYLOCOCCUS;
BACTERIA (MICROORGANISMS);
LACTOBACILLUS;
LACTOBACILLUS GASSERI;
POSIBACTERIA;
STAPHYLOCOCCUS;
|
EID: 0035106851
PISSN: 13645072
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2672.2001.01251.x Document Type: Article |
Times cited : (92)
|
References (36)
|